202 related articles for article (PubMed ID: 18313561)
21. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
Jones AP; Riley RD; Williamson PR; Whitehead A
Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
[TBL] [Abstract][Full Text] [Related]
22. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells.
Rücker G; Schwarzer G; Carpenter J; Olkin I
Stat Med; 2009 Feb; 28(5):721-38. PubMed ID: 19072749
[TBL] [Abstract][Full Text] [Related]
23. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
Thorlund K; Devereaux PJ; Wetterslev J; Guyatt G; Ioannidis JP; Thabane L; Gluud LL; Als-Nielsen B; Gluud C
Int J Epidemiol; 2009 Feb; 38(1):276-86. PubMed ID: 18824467
[TBL] [Abstract][Full Text] [Related]
24. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses.
Brok J; Thorlund K; Gluud C; Wetterslev J
J Clin Epidemiol; 2008 Aug; 61(8):763-9. PubMed ID: 18411040
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis and meta-analytic monitoring of clinical trials.
Feinstein AR
Stat Med; 1996 Jun; 15(12):1273-80; discussion 1281-3. PubMed ID: 8817801
[TBL] [Abstract][Full Text] [Related]
26. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
27. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW
Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490
[TBL] [Abstract][Full Text] [Related]
28. The conditional relative odds ratio provided less biased results for comparing diagnostic test accuracy in meta-analyses.
Suzuki S; Moro-oka T; Choudhry NK
J Clin Epidemiol; 2004 May; 57(5):461-9. PubMed ID: 15196616
[TBL] [Abstract][Full Text] [Related]
29. Practical and updated guidelines on performing meta-analyses of non-randomized studies in interventional cardiology.
Navarese EP; Koziński M; Pafundi T; Andreotti F; Buffon A; Servi SD; Kubica J
Cardiol J; 2011; 18(1):3-7. PubMed ID: 21305479
[TBL] [Abstract][Full Text] [Related]
30. Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers.
Flannery G; Gehrig-Mills R; Billah B; Krum H
Am J Cardiol; 2008 Mar; 101(6):865-9. PubMed ID: 18328855
[TBL] [Abstract][Full Text] [Related]
31. One relative risk versus two odds ratios: implications for meta-analyses involving paired and unpaired binary data.
Zou GY
Clin Trials; 2007; 4(1):25-31. PubMed ID: 17327243
[TBL] [Abstract][Full Text] [Related]
32. The questionable association of vitamin E supplementation and mortality--inconsistent results of different meta-analytic approaches.
Gerss J; Köpcke W
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55 Suppl():OL1111-20. PubMed ID: 19267994
[TBL] [Abstract][Full Text] [Related]
33. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
Zhao YT; Chen Q; Sun YX; Li XB; Zhang P; Xu Y; Guo JH
Ann Med; 2009; 41(4):301-10. PubMed ID: 19148838
[TBL] [Abstract][Full Text] [Related]
34. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
Manchikanti L; Datta S; Smith HS; Hirsch JA
Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of heterogeneous clinical trials: an empirical example.
Doi SA; Barendregt JJ; Mozurkewich EL
Contemp Clin Trials; 2011 Mar; 32(2):288-98. PubMed ID: 21147265
[TBL] [Abstract][Full Text] [Related]
36. The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events.
Leombruno JP; Einarson TR; Keystone EC
Ann Rheum Dis; 2009 Jul; 68(7):1136-45. PubMed ID: 18753157
[TBL] [Abstract][Full Text] [Related]
37. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
Ding L; Hua W; Niu H; Chen K; Zhang S
Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
[TBL] [Abstract][Full Text] [Related]
38. Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials.
Mannucci E; Monami M; Lamanna C; Gensini GF; Marchionni N
Diabetes Obes Metab; 2008 Dec; 10(12):1221-38. PubMed ID: 18505403
[TBL] [Abstract][Full Text] [Related]
39. Publication bias was not a good reason to discourage trials with low power.
Borm GF; den Heijer M; Zielhuis GA
J Clin Epidemiol; 2009 Jan; 62(1):47.e1-10. PubMed ID: 18620841
[TBL] [Abstract][Full Text] [Related]
40. Optimizing the use of patient data to improve outcomes for patients: narcotics for chronic noncancer pain.
Busse JW; Guyatt GH
Expert Rev Pharmacoecon Outcomes Res; 2009 Apr; 9(2):171-9. PubMed ID: 19402805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
